IDiyas

For the Inventor, By the Inventor

Kawasaki, Japan

Hiroyuki Matsueda

USPTO Granted Patents = 16

Average Co-Inventor Count = 6.7

ph-index = 4

Forward Citations = 69(Granted Patents)


Company Filing History:

goldMedal16 out of 1,929 
 
Ajinomoto Co., Ltd.
 patents

Years Active: 1999-2011

Loading Chart...
16 patents (USPTO):Explore Patents
1. 7956041 - Prophylactic and therapeutic agent of diabetes mellitus (2011-06-07),
2. 7645787 - Pyrazole derivatives and diabetic medicine containing them (2010-01-12),
3. 7632830 - Lactam compounds and pharmaceutical use thereof (2009-12-15),
4. 7326701 - Lactam compounds and pharmaceutical use thereof (2008-02-05),
5. 7256209 - Pyrazole derivatives and diabetic medicine containing them (2007-08-14),
6. 7247645 - Dihydropyridine derivatives (2007-07-24),
7. 7247616 - Pyrazole derivatives and diabetic medicine containing them (2007-07-24),
8. 7153850 - Lactam compounds and pharmaceutical use thereof (2006-12-26),
9. 7015201 - Pyrazole derivatives and diabetic medicine containing them (2006-03-21),
10. 6930205 - Process for preparing aminostilbene derivatives (2005-08-16),
11. 6908905 - N-substituted pyrazole-O-glycoside derivatives and therapeutic agent for diabetes containing the same (2005-06-21),
12. 6815428 - Pyrazole derivatives and diabetic medicine containing them (2004-11-09),
13. 6784315 - Stilbene derivative crystal and method for producing the same (2004-08-31),
14. 6258975 - Process for producing optically active 2-hydroxy-4-arylbutyric acid or its ester (2001-07-10),
15. 6087526 - Process for producing optically active 2-hydroxy-4-arylbutyric acid or (2000-07-11),

Title: Hiroyuki Matsueda: Innovator in Diabetes Treatment

Introduction

Hiroyuki Matsueda is a prominent inventor based in Kawasaki, Japan. He has made significant contributions to the field of diabetes treatment, holding a total of 16 patents. His innovative work focuses on developing effective therapeutic agents for managing diabetes mellitus.

Latest Patents

Matsueda's latest patents include a prophylactic and therapeutic agent for diabetes mellitus. This invention combines an inhibitor of renal glucose reabsorption with a hypoglycemic agent, effectively ameliorating hyperglycemia after meals, between meals, and during fasting. Additionally, he has developed pyrazole derivatives used as diabetic medicine, represented by specific chemical formulae.

Career Highlights

Matsueda has had a distinguished career, primarily working with Ajinomoto Co., Ltd. His research and inventions have paved the way for new treatments that enhance the quality of life for individuals suffering from diabetes.

Collaborations

He has collaborated with notable colleagues, including Toshihiro Hatanaka and Nobuo Kondo, contributing to advancements in diabetes research and treatment.

Conclusion

Hiroyuki Matsueda's innovative contributions to diabetes treatment through his patents and collaborations highlight his importance in the field. His work continues to impact the lives of many individuals managing diabetes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…